A rapid screening test for detection of drugs of abuse substances in biological samples. Used for workplace testing and clinical screening applications.
Hangzhou Lysun Biotechnology Co., Ltd. is a biomedical company specializing in in-vitro diagnostic reagents and medical instruments, established in 2018. The company holds EN ISO 13485:2016 certification and CE marking, with over 20 patents. Lysun focuses on POCT products for self-testing, clinical biochemistry, and immunology, including COVID-19 antibody and antigen detection kits approved for export to multiple countries.
✦ Product-Specific Coverage
AI supplier coverage for this product
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.